Status:
UNKNOWN
Individual vs. Group Hypnotherapy in Patients With Irritable Bowel Syndrome
Lead Sponsor:
Sahlgrenska University Hospital
Conditions:
IBS - Irritable Bowel Syndrome
Eligibility:
All Genders
18-67 years
Phase:
NA
Brief Summary
Patients' fulfilling Rome III criteria for IBS with symptoms refractory to standard treatment who are referred to a specialist unit for hypnotherapy are consecutively included in the study. The patien...
Detailed Description
Patients' fulfilling Rome III criteria for IBS with symptoms refractory to standard treatment who are referred to a specialist unit for hypnotherapy are consecutively included in the study. Firstly, t...
Eligibility Criteria
Inclusion
- IBS according to Rome III criteria
Exclusion
- Organic GI disease
Key Trial Info
Start Date :
August 15 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2025
Estimated Enrollment :
119 Patients enrolled
Trial Details
Trial ID
NCT03432078
Start Date
August 15 2011
End Date
December 31 2025
Last Update
December 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dept of Internal Medicine, Sahlgrenska University Hospital
Gothenburg, Sweden, 41345